A new option for adults who have experienced stroke will now be available to further reduce future risk.
News|Articles|October 3, 2007
OTC cough, cold medicine in children under six under FDA review
FDA advisory committee to discuss OTC cough/ cold products in children under six
Advertisement
The FDA is asking for advice from its advisory committees about the use of cough and cold products in children under six years of age. The agency reviews pertain to both single-ingredient products and products that include multiple combinations of ingredients. The FDA is making the background briefing information available for the Oct. 18 and 19 Nonprescription Drugs and Pediatric Advisory Committees joint meeting at
To go to the Drug Topics homepage,
Advertisement
Related to this article
Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.
Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.
Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.
Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.
Investigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.
Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Asundexian, First FXIa Inhibitor for Stroke Prevention
2
The Outcome-Based Program That Could Reshape Pharmacists’ Roles
3
High Triglycerides Independently Linked with Severe COVID-19 Death
4
US Lost Over 3000 Pharmacies From 2022 to 2024, Mostly Chains
5